• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT SYSTEM Back to Search Results
Catalog Number EX051703C
Device Problem Fracture (1260)
Patient Problem Injury (2348)
Event Date 04/25/2019
Event Type  Injury  
Manufacturer Narrative
A medical image was provided to the manufacturer for review.The lot number for the device was provided.The device history records are currently under review.The device is not available for return.The investigation is currently underway.
 
Event Description
It was reported that seven working days post stent placement via a contralateral femoral artery approach to treat lower extremity arteriosclerosis obliterans, the stent was allegedly identified as fractured via angiogram.It was further reported that a short stent was allegedly placed at the fracture point.The patient was stable at the conclusion of the second stent placement procedure.
 
Event Description
It was reported that seven working days post stent placement via a contralateral femoral artery approach to treat lower extremity arteriosclerosis obliterans, the stent was allegedly identified as fractured via angiogram.It was further reported that a short stent was allegedly placed at the fracture point.The patient was stable at the conclusion of the second stent placement procedure.
 
Manufacturer Narrative
H10: manufacturing review: review of manufacturing records was not performed, as no additional complaint has been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.Investigation summary: video clips and images were provided.Based on the date shown in the video, the recordings were taken on the date of event.However, only the third image is showing placed stents inside the patients vessel.Based on the resolution of the videos a detailed evaluation of the placed stent in particular the integrity of the stent could not be performed.Therefore, an alleged stent fracture could not be confirmed.Based on the information available a definite root cause for the reported event could not be identified.Labeling review: in reviewing the current labeling for this product it was found that the instructions for use (ifu) sufficiently address this potential risk.The ifu describes the stent deployment procedure by stating: "confirm that the introducer sheath is secure and will not move during deployment (.) to ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment (.) do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.(.) initiate stent deployment by rotating the thumbwheel in the direction of the arrows while holding the handle in a fixed position.(.) while maintaining a fixed handle position, rotate thumbwheel to obtain initial stent wall apposition of 1cm minimum.(.) with distal end of the stent apposing the vessel wall, deployment continues with the following method (.) while maintaining a fixed handle position, place your finger in front of the deployment slide and slide it from the distal to proximal end." balloon pre and post dilation is addressed: "predilation of the lesion should be performed using standard techniques." and "post stent expansion with a pta catheter is recommended." h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT VASCULAR STENT SYSTEM
Type of Device
VASCULAR STENT SYSTEM
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key8724461
MDR Text Key148920815
Report Number9681442-2019-00078
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519007786
UDI-Public(01)04049519007786
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2021
Device Catalogue NumberEX051703C
Device Lot NumberANDN1245
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/30/2019
Initial Date FDA Received06/21/2019
Supplement Dates Manufacturer Received08/16/2019
Supplement Dates FDA Received08/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
-
-